A Metabolic Axis of Immune Intractability

Area of Science:

• * Immunology
• * Developmental Biology
• * Cancer Biology

Background:

• * Immune cells significantly impact tumor progression and disease outcome.
• * Developmental pathways are reactivated in cancer, showing parallels with embryonic development.
• * Both embryonic development and tumor microenvironments exhibit immune-suppressive characteristics.

Purpose of the Study:

• * To explore the convergence of immune programming during ontogeny and in the tumor microenvironment.
• * To highlight the role of metabolic pathways in regulating immune cell function in cancer.
• * To investigate the integration of developmental and tumor immune regulation.

Main Methods:

• * Review of existing literature on immune regulation in embryonic development and cancer.
• * Focus on the Hedgehog (Hh) signaling pathway and its dysregulation.
• * Analysis of the hexosamine biosynthetic pathway (HBP) and its metabolic products.

Main Results:

• * Metabolic and bioenergetic circuits guide immune cell differentiation and function in both developing embryos and tumors.
• * The hexosamine biosynthetic pathway (HBP) integrates key nutrients to produce UDP-GlcNAc, a crucial metabolic sensor.
• * Dysregulation of Hh activity exemplifies the convergence of developmental and tumor immune programming.

Conclusions:

• * Immune regulation during ontogeny and tumor progression share common mechanisms, particularly immune suppression.
• * O-GlcNAcylation, regulated by the HBP, plays a critical role in orchestrating immune suppression in the tumor microenvironment.
• * Targeting metabolic pathways offers potential strategies for modulating immune responses in cancer.